


Searching News Database: Abraxis Pharmaceutical Products
HSMN NewsFeed - 2 Dec 2009
Thomas H. Silberg to Retire as President and CEO of APP Pharmaceuticals, John Ducker Named as Successor
Thomas H. Silberg to Retire as President and CEO of APP Pharmaceuticals, John Ducker Named as Successor
HSMN NewsFeed - 10 Aug 2007
APP Receives Expedited Approval for the First and Only Generic Cefotetan Disodium for Injection
APP Receives Expedited Approval for the First and Only Generic Cefotetan Disodium for Injection
HSMN NewsFeed - 7 Aug 2007
Abraxis BioScience Receives FDA Approval for Oxytocin Injection 10 USP Units/mL in a 30 mL Vial
Abraxis BioScience Receives FDA Approval for Oxytocin Injection 10 USP Units/mL in a 30 mL Vial
HSMN NewsFeed - 28 Nov 2006
Abraxis BioScience Receives FDA Approval for Ampicillin and Sulbactam for Injection, 15g, USP
Abraxis BioScience Receives FDA Approval for Ampicillin and Sulbactam for Injection, 15g, USP
HSMN NewsFeed - 4 Oct 2006
Arixtra(R) Receives Priority Review by the FDA in Acute Coronary Syndromes (ACS)
Arixtra(R) Receives Priority Review by the FDA in Acute Coronary Syndromes (ACS)
HSMN NewsFeed - 8 Sep 2006
Abraxis BioScience Names Leadership Team for Its Abraxis Pharmaceutical Products Division
Abraxis BioScience Names Leadership Team for Its Abraxis Pharmaceutical Products Division
Additional items found! 2
Members Archive contains
2 additional stories matching:
Abraxis Pharmaceutical Products
(Password required)
Abraxis Pharmaceutical Products
(Password required)
